Category Archives: Jim’s Corner

California’s Assembly and Senate have both overwhelmingly passed Senate Bill 598, legislation that creates a pathway for the substitution of interchangeable biologic medicines. Despite fierce opposition from insurance companies and large pharmacy chains, it is now on its way to the Governor’s desk. It’s critical for him to understand that this issue is one of the highest priorities for patients, healthcare providers and the life sciences industry. Senate Bill 598 is needed now to update Read More >

BIO elected five new members to its Board of Directors, voted upon at this year’s Board Meetings, held last week in Washington, DC. The following individuals were elected to the Health Section Governing Board: Francois Nader, President & CEO of NPS Pharmaceuticals, Inc. Anna Protopapas, President of Millennium: The Takeda Oncology Company Allen Waxman, Senior Vice President and General Counsel of Eisai, Inc. Klaus Wilgenbus, Senior Vice President, Business Development & Licensing of Boehringer Ingelheim Read More >